THERAPEUTIC COMPOUNDS

• 收藏
• 分享

专利权人:

Inc.;Gilead Sciences

发明人:

Ramanathan, Srinivasan

申请号：

AU2016203666

公开号：

AU2016203666A1

申请日:

2016.06.02

申请国别(地区):

AU

年份:

2016

代理人:

摘要：

#$%^&*AU2016203666A120160623.pdf#####H:Vec Interwoven NRPortbl DCC REC I0236264_I.docx-31/05/2016 ABSTRACT The use of the hemifumarate form of {9-[(R)-2-[[(S)-[[(S)-1(isopropoxycarbonyl)ethyl] amino]phenoxyphosphinyl]methoxy]propyl] adenine I (tenofovir alafenamide hemifumarate) in combination with cobicistat is disclosed. In addition, the combination of tenofovir alafenamide hemifumarate, cobicistat, emtricitabine, and elvitegravir, and the combination of tenofovir alafenamide hemifumarate, cobicistat, emtricitabine, and darunavir, are disclosed.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/